Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice.
about
Tracks through the genome to physiological eventsIn Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide MetforminDevelopment of a Drosophila melanogaster spliceosensor system for in vivo high-throughput screening in myotonic dystrophy type 1.An alanine expanded PABPN1 causes increased utilization of intronic polyadenylation sites.Hybrid splicing minigene and antisense oligonucleotides as efficient tools to determine functional protein/RNA interactions.Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1.
P2860
Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice.
@en
type
label
Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice.
@en
prefLabel
Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice.
@en
P2093
P2860
P356
P1433
P1476
Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice.
@en
P2093
Ichizo Nishino
Kosuke Oana
Masanori P Takahashi
Satoshi Suo
Shin'ichi Takeda
Shoichi Ishiura
P2860
P2888
P356
10.1038/SREP02142
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1034221910